Imprivata

Imprivata was founded by David Ting and Phil Scarfo, who had developed identity management technology while working at Polaroid Corporation’s small business incubator.

The company shipped its first product, the OneSign Enterprise Single Sign-on appliance, in 2004. In 2005, Imprivata expanded to Europe, Africa and the Middle East, and in 2006 Imprivata founder David Ting was selected by InfoWorld as one of the top 25 chief technology officers of the year.

In 2009, Imprivata acquired the assets of IdentiPHI, a manufacturer and reseller of biometric technology, including the SAFsolution product line, and in 2011, acquired assets of Validus Medical Systems of Santa Cruz, California, which was incorporated into the Imprivata Cortext technology.

In July 2016, Imprivata announced that it agreed to be acquired by Thoma Bravo, a private equity firm based in San Francisco, for $19.25 per share, estimated at a total of $544 million. Omar Hussain was the chief executive at the time.

Imprivata OneSign helps companies manage user access and authentication. Product reviews suggest that OneSign allows companies to enable all enterprise applications for single sign-on without requiring custom scripting or modifications to existing directories. OneSign can also strengthen user authentication to desktops and networks by replacing passwords with a range of authentication options that include finger biometrics, proximity cards, smart cards, many national and government ID cards, One-Time-Password tokens, and an employee’s physical location. Product reviews also comment on OneSign's ability to simplify compliance reporting by consolidating the employee strong authentication and application access events in a single database.